Pasi A. Jänne
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies 158
- Lung Cancer Research Studies 142
- HER2/EGFR in Cancer Research 113
- Pulmonary and Respiratory Medicine top 0.01%
- Lung Cancer Treatments and Mutations 487
- Lung Cancer Diagnosis and Treatment 89
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics 107
- Molecular Biology top 0.05%
- Cancer therapeutics and mechanisms 59
- PI3K/AKT/mTOR signaling in cancer 41
- Pathology and Forensic Medicine top 0.05%
- Co-authors
- Bruce E. JohnsonMatthew MeyersonMichael J. EckJeffrey A. EngelmanNeal I. LindemanTitus J. BoggonGeoffrey R. OxnardWilliam R. Sellers
- Journals
- Journal of Clinical Oncology (171 papers)Journal of Thoracic Oncology (75 papers)Annals of Oncology (64 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Pasi A. Jänne
628 papers receiving 60.2k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Oncology 35.9k
- Pulmonary and Respiratory Medicine 40.7k
- Cancer Research 13.6k
- Molecular Biology 25.7k
- Pathology and Forensic Medicine 4.9k
Countries citing papers authored by Pasi A. Jänne
This map shows the geographic impact of Pasi A. Jänne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasi A. Jänne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasi A. Jänne more than expected).
Fields of papers citing papers by Pasi A. Jänne
This network shows the impact of papers produced by Pasi A. Jänne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasi A. Jänne. The network helps show where Pasi A. Jänne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pasi A. Jänne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 250 | |
| 2 | 2018 | 69 | |
| 3 | 2018 | 290 | |
| 4 | Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activitybreakdown → | 2016 | 523 |
| 5 | 2016 | 114 | |
| 6 | 2015 | 159 | |
| 7 | 2014 | 79 | |
| 8 | 2013 | 274 | |
| 9 | 2013 | 51 | |
| 10 | 2011 | 168 | |
| 11 | 2011 | 9 | |
| 12 | 2011 | 109 | |
| 13 | 2011 | 68 | |
| 14 | 2011 | 110 | |
| 15 | 2011 | 4 | |
| 16 | Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Populationbreakdown → | 2009 | 526 |
| 17 | MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signalingbreakdown → | 2007 | 3570 |
| 18 | 2007 | 137 | |
| 19 | 2007 | 174 | |
| 20 | EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapybreakdown → | 2004 | 7539 |
About Pasi A. Jänne
Pasi A. Jänne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 653 papers that have together received 61.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (487 papers), Colorectal Cancer Treatments and Studies (158 papers), Lung Cancer Research Studies (142 papers), HER2/EGFR in Cancer Research (113 papers), Cancer Genomics and Diagnostics (107 papers), Lung Cancer Diagnosis and Treatment (89 papers), Cancer therapeutics and mechanisms (59 papers) and PI3K/AKT/mTOR signaling in cancer (41 papers). The work is most often cited by research in Oncology (35.9k citations), Pulmonary and Respiratory Medicine (40.7k citations) and Cancer Research (13.6k citations). Pasi A. Jänne has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Bruce E. Johnson, Matthew Meyerson, Michael J. Eck, Jeffrey A. Engelman, Neal I. Lindeman, Titus J. Boggon, Geoffrey R. Oxnard, William R. Sellers, Heidi Greulich and Sean Tracy. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.